Structure |
Chemical Name |
CAS |
MF |
|
Gliclazide Impurity A |
|
|
|
Medetomidine Impurity 14 |
79924-14-4 |
C13H16N2 |
|
Tenofovir Disoproxil Impurity B |
36817-69-3 |
C8H11N5O |
|
Ipragliflozin IMP |
|
|
|
2-Propanone, 1,3-bis(4-methoxyphenyl)- |
29903-09-1 |
C17H18O3 |
|
1-NaphthaleneMethanaMine, α-Methyl-N-[[3-(trifluoroMethyl)phenyl]Methyl]-, (αR)- |
1229512-52-0 |
C20H18F3N |
|
Benzoic acid, 2-[[[[(5S)-2-oxo-3-[4-(3-oxo-4-Morpholinyl)phenyl]-5-oxazolidinyl]Methyl]aMino]carbonyl]- |
1365267-37-3 |
C22H21N3O7 |
|
NSC 609249 |
51012-67-0 |
C12H20ClNO2 |
|
1-[(4-Ethoxy-3-formylphenyl)sulfonyl]-4-methylpiperazine |
332374-42-2 |
C14H20N2O4S |
|
ApovincaMinic Acid Ethyl Ester N-Oxide |
109741-24-4 |
C22H26N2O3 |
|
(2R,4S)-ethyl 5-([1,1'-biphenyl]-4-yl)-4-aMino-2-Methylpentanoate |
752174-62-2 |
C20H25NO2 |
|
EMpagliflozin iMpurity 12 |
|
|
|
(2S,4R)-Teneligliptin |
1404559-15-4 |
C22H30N6OS |
|
Daclatasvir Impurity |
1417333-83-5 |
C40H50N8O6 |
|
(3aS,12bS)-2-Methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrole |
65576-39-8 |
C17H17NO |
|
1-[2-[(3,4-diMethylphenyl)thio]phenyl]- Piperazine |
1293489-74-3 |
C18H22N2S |
|
N-acetyl-N-(2-(7-Methoxynaphthalen-1-yl)ethyl)acetaMide |
1379005-34-1 |
C17H19NO3 |
|
N-acetyl-N-(2-(7-Methoxynaphthalen-1-yl)ethyl)acetaMide |
1379005-34-1 |
C17H19NO3 |
|
3-(1-Naphthalenyloxy)propiophenone |
41198-42-9 |
C19H16O2 |
|
2-(1,3,2-Dioxaborinan-2-yl)benzamide |
2377611-18-0 |
C10H12BNO3 |
|
carfilzoMib iMpurity -A |
|
|
|
(3S,4R)-1-(4-fluorophenyl)-3-((S)-3-(4-fluorophenyl)-3-hydroxypropyl)-4-(4-hydroxyphenyl)azetidin-2-one |
1593543-00-0 |
C24H21F2NO3 |
|
ethyl N-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)Methyl)-N-pentanoyl-L-valinate |
1111177-30-0 |
C26H33N5O3 |
|
Rosuvastatin EP impurity A |
1714147-50-8 |
C25H34FN3NaO7S* |
|
Doxorubicin Impurity 6 |
69429-21-6 |
C26H27NO11 |
|
Etoricoxib Impurity 11 |
202409-31-2 |
C17H13ClN2O2S |
|
Levofloxacin Tetrafluoro Impurity 1 |
110548-02-2 |
C15H15F4NO4 |
|
Penicillin F Potassium Salt |
97299-13-3 |
C14H21KN2O4S |
|
Olaparib Impurity 31 |
458535-34-7 |
C12H18N2O2 |
|
Macitentan impurity A |
441798-25-0 |
C17H16Br2N6O4S |
|
4-(3,4-DICHLOROPHENYL)-3,4-DIHYDRO-2H-NAPHTHALEN-1-ONE OXIME |
152642-35-8 |
C16H13Cl2NO |
|
3-Pyridinecarboxylic acid, 6-(4-carboxy-1-piperidinyl)-5-chloro- |
958457-83-5 |
C12H13ClN2O4 |
|
Linagliptin Impurity C |
|
|
|
Parecoxib Impurity B |
|
|
|
Vildagliptin impurity E |
|
|
|
3-propylisobenzofuran-1(3H)-one |
72424-08-9 |
C11H12O2 |
|
Axitinib Sulfonyl |
1348536-59-3 |
C22H18N4O3S |
|
Atracurium Impurity B |
87046-74-0 |
|
|
(R)-4-fluoro-2-((3-methyl-6-(3-((1-methyl-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)amino)piperidin-1-yl)-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile |
|
C23H24FN7O4 |
|
2-(2-fluorophenyl)-1-(1H-1,2,4-triazol-1-yl)-3-(4H-1,2,4-triazol-4-yl)propan-2-ol |
|
C13H13FN6O |
|
Dapagliflozin Impurity 10 |
960404-86-8 |
C21H25ClO7 |
|
Ibrutinib Impurity 6 |
1917333-91-5 |
C28H26N6O3 |
|
Imatinib Impurity 5 |
|
|
|
Mirabegron Impurity 8 HCl |
1684452-81-0 |
C21H24N4O2S |
|
Regorafenib Impurity 2 |
|
|
|
Vonoprazan Impurity 5 |
|
|
|
Bendamustine |
1219709-86-0 |
C14H18ClN3O2 |
|
Dapagliflozin Impurity E |
|
|
|
Febuxostat Impurity 14 |
1335202-60-2 |
C15H16N2OS |
|
Kaempferol 3-robinoside 7-glucoside |
114924-89-9 |
C33H40O20 |
|
Vitexin 7-glucoside |
35109-95-6 |
C27H30O15 |
|
2-amino-9-((1S,3S,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl)-1,9-dihydro-6H-purin-6-one |
1367369-77-4 |
C12H15N5O3 |
|
Carfilzomib Impurity B |
|
|
|
Ornidazole Impurity 1 |
1100750-18-2 |
|
|
Prednicarbate Related Compound C (20 mg) (prednisolone-21-propionate) |
5740-62-5 |
C24H32O6 |
|
ethyl 2-(3-hydroxyphenyl)-4-methylthiazole-5-Carboxylate |
209538-87-4 |
C13H13NO3S |
|
Pyridine, 3-Methoxy-2-Methyl-4-nitro-, 1-oxide |
15931-25-6 |
C7H8N2O4 |
|
1H,3H,5H-pyrrolo[1,2-a]thiazolo[3,4-d]pyrazine5,8,10(5aH,10aH)-trione,dihydro- |
161771-76-2 |
C9H10N2O3S |
|
(Z)-Methyl 3-aMino-4-(2,4,5-trifluorophenyl)but-2-enoate |
881995-70-6 |
C11H10F3NO2 |
|
6-(benzyloxy)-8-(2-broMoacetyl)-2H-benzo[b][1,4]oxazin-3(4H)-one |
926319-53-1 |
C17H14BrNO4 |
|
(2S)-1-[(2S)-2-[[(1S)-3-Phenyl-1-[(2phenylethoxy) carbonyl]propyl]aMino]propanoyl]pyrrolidine-2-carboxylic acid |
|
C26H31N2O5 |
|
2-(5-Benzyl-3,6-dioxopiperazin-2-yl)acetic Acid
(Diketopiperazine) |
|
C29H42N8O18S4 |
|
Methoxyvinpocetine |
|
|
|
Butanoic acid, 4-chloro-3-hydroxy-, (3S)- |
106941-19-9 |
C4H7ClO3 |
|
Anastrozole iMpurity D |
|
|
|
Anastrozole iMpurity D |
|
|
|
EMtricitabine iMpurity D |
|
|
|
IMp. D (EP) as SodiuM Salt |
|
|
|
RocuroniuMbroMide iMpurity G |
|
|
|
5,11-bisthio-(R,R)-1,7-diazatricyclo[7.3.0.07,11]dodecane-2,8-diketone |
72744-67-3 |
C8H10N2O2S2 |
|
(1S,2S,3R,4R)-Methyl 3-((R)-1-acetaMido-2-ethylbutyl)-4-guanidino-2-hydroxycyclopentanecarboxylate |
229614-51-1 |
C16H30N4O4 |
|
Bis(4-fluorobenzyl)aMine, 97% |
134227-41-1 |
C14H13F2N |
|
(3S,8R,9S,12S)-3,12-Bis(1,1-diMethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylMethyl)-6-[[4-(2-pyridinyl)phenyl]Methyl]-,2,5,6,10,13-pentaazatetradecanedioic Acid 1,14-DiMethyl Ester |
1292296-09-3 |
C38H52N6O7 |
|
L-Leucine 2-[(2-AMino-1,6-dihydro-6-oxo-9H-purin-9-yl)Methoxy]ethyl Ester Hydrochloride |
142963-69-7 |
C14H23ClN6O4 |
|
8-Chloro-6,11-dihydro-11-(1,2,3,6-tetrahydro-4-pyridinyl-5H-benzo[5,6]cyclohepta[1,2-b]pyridine Monohydrochloride |
432543-89-0 |
C19H20Cl2N2 |
|
1-[(2'-Cyano[1,1'-biphenyl]-4-yl)MethylaMino]-N-pentanoylcyclopentanecarboxaMide |
141745-71-3 |
C25H29N3O2 |
|
PF 2825 |
153012-65-8 |
C21H28N2O5S |
|
3,3'-[Dithiobis[(2S,4S)-4,2-pyrrolidinediylcarbonyliMino]]bisbenzoic Acid Dihydrochloride |
444057-64-1 |
C24H27ClN4O6S2 |
|
Ertapenem Dimer Form D Impurity |
1199797-41-5 |
C44H50N6O14S2 |
|
S 00218 |
92700-82-8 |
C15H22N2O4 |
|
2-Methyl-2-(4-vinylphenyl)propanoic acid |
1256584-72-1 |
C12H14O2 |
|
2-Methyl-2-(4-vinylphenyl)propanoic acid |
1256584-72-1 |
C12H14O2 |
|
Loratadine IMpurity D |
|
C22H23ClN2O2 |
|
PeMetrexed EP IMpurity A |
869791-42-4 |
C21H23N5O6 |
|
Itraconazole EP IMpurity G |
|
|
|
(1R,2S)-2-(3,4-difluorophenyl)cyclopropanaMine hydrochloride |
1402222-66-5 |
C9H10ClF2N |
|
IMp. E (EP): 1,4-Bis(diphenylMethyl)piperazine |
216581-01-0 |
C30H30N2 |
|
21-Dehydro-6α-Methyl Prednisolone |
58636-50-3 |
C22H28O5 |
|
α-Hydroxy Flurbiprofen |
61466-95-3 |
C15H13FO3 |
|
5-(2-cyclopropyl-2-oxo-1-phenylethyl)-4,5,6,7-tetrahydrothieno [3,2-c]pyridin-2-yl acetate |
1391194-45-8 |
C20H21NO3S |
|
9-AcridinaMine, 6-chloro-2-ethoxy- |
855939-48-9 |
C15H13ClN2O |
|
1-(6-Methylpyridin-3-yl)-2-(4-(Methylthio)phenyl)ethanone |
221615-72-1 |
C15H15NOS |
|
Edaravone |
68195-63-1 |
C30H26N6O3 |
|
Erlotinib IMpurity C |
1312937-41-9 |
C15H20N2O5 |
|
Cinacalcet IMpurity |
1229224-93-4 |
C22H26F3N |
|
SalMeterol iMpurity |
144391-74-2 |
C25H37NO4 |
|
AzithroMycin iMpurity R |
|
|
|
ceftazidiMe iMpurity E |
|
|
|
CefuroxiMe Axetil iMpurity C |
76598-06-6 |
C18H15Cl3N4O9S |
|
Rupatadine iMpurity D |
|
|